Berkeley Capital Partners LLC Cuts Position in Procter & Gamble Co (NYSE:PG)

Berkeley Capital Partners LLC lowered its stake in Procter & Gamble Co (NYSE:PG) by 4.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 6,156 shares of the company’s stock after selling 267 shares during the quarter. Berkeley Capital Partners LLC’s holdings in Procter & Gamble were worth $766,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of the company. Slow Capital Inc. grew its stake in Procter & Gamble by 3.9% during the 2nd quarter. Slow Capital Inc. now owns 2,317 shares of the company’s stock valued at $254,000 after purchasing an additional 86 shares in the last quarter. AMI Asset Management Corp grew its stake in Procter & Gamble by 0.7% during the 3rd quarter. AMI Asset Management Corp now owns 13,431 shares of the company’s stock valued at $1,671,000 after purchasing an additional 87 shares in the last quarter. Stony Point Wealth Management Inc. grew its position in shares of Procter & Gamble by 0.7% in the 2nd quarter. Stony Point Wealth Management Inc. now owns 12,805 shares of the company’s stock worth $1,485,000 after acquiring an additional 91 shares in the last quarter. Centric Wealth Management grew its position in shares of Procter & Gamble by 0.9% in the 3rd quarter. Centric Wealth Management now owns 10,692 shares of the company’s stock worth $1,295,000 after acquiring an additional 91 shares in the last quarter. Finally, First Mercantile Trust Co. grew its position in shares of Procter & Gamble by 1.5% in the 3rd quarter. First Mercantile Trust Co. now owns 6,164 shares of the company’s stock worth $767,000 after acquiring an additional 92 shares in the last quarter. Institutional investors and hedge funds own 65.62% of the company’s stock.

Shares of NYSE PG opened at $120.32 on Thursday. The company has a market cap of $308.91 billion, a price-to-earnings ratio of 26.62, a price-to-earnings-growth ratio of 3.48 and a beta of 0.42. Procter & Gamble Co has a 12-month low of $86.74 and a 12-month high of $125.77. The company has a current ratio of 0.72, a quick ratio of 0.54 and a debt-to-equity ratio of 0.44. The stock’s 50 day simple moving average is $122.05 and its 200 day simple moving average is $114.88.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Tuesday, October 22nd. The company reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.13. The business had revenue of $17.80 billion for the quarter, compared to the consensus estimate of $17.43 billion. Procter & Gamble had a return on equity of 25.07% and a net margin of 6.24%. The business’s revenue was up 6.6% on a year-over-year basis. During the same quarter last year, the business posted $1.12 EPS. As a group, equities analysts forecast that Procter & Gamble Co will post 4.93 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a $0.7459 dividend. This represents a $2.98 annualized dividend and a dividend yield of 2.48%. The ex-dividend date is Thursday, October 17th. Procter & Gamble’s dividend payout ratio (DPR) is 65.93%.

Several brokerages have recently commented on PG. Wells Fargo & Co lifted their target price on Procter & Gamble from $135.00 to $136.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 23rd. ValuEngine lowered Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Goldman Sachs Group reiterated a “buy” rating and issued a $136.00 target price on shares of Procter & Gamble in a research report on Wednesday, October 23rd. UBS Group lifted their target price on Procter & Gamble from $122.00 to $126.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 23rd. Finally, Morgan Stanley lifted their target price on Procter & Gamble from $130.00 to $134.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 23rd. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and ten have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $115.00.

In related news, Chairman David S. Taylor sold 87,643 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $119.32, for a total value of $10,457,562.76. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Carolyn M. Tastad sold 10,662 shares of Procter & Gamble stock in a transaction on Monday, August 26th. The shares were sold at an average price of $118.00, for a total value of $1,258,116.00. Following the sale, the insider now directly owns 61,225 shares in the company, valued at approximately $7,224,550. The disclosure for this sale can be found here. In the last three months, insiders sold 1,645,966 shares of company stock worth $202,229,770. Company insiders own 1.75% of the company’s stock.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.

Recommended Story: What Does a Sell-Side Analyst Rating Mean?

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.